- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03121040
Clinical Trial for Vespa Amino Acid Mixture (VAAM®)
Improved ATP Generation Efficiency for Younger Athletes by Ingestion of a Vespa Amino Acid Mixture
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The subjects were instructed to maintain their usual dietary habits in addition to drinking VAAM® (two cans every day) for 10 weeks. In detail, on the 6 days/week of supervised running tests, participants were instructed to consume one drink before their warm-up exercise and the other drink while running. During their sessions and without supervision (1 day/week), participants were also instructed to consume one drink in the morning after breakfast and the other drink in the evening after dinner.
The subjects were divided into three groups for the running tests: 3 males were assigned to group 1, which involved training for the 1500-meter race; 2 males were assigned to group 2, which involved training for the 800-meter race; and 1 male and 3 females were assigned to group 3, which involved training for the 400-meter race. The running exercises began with a 45 min warm-up (including jogging, leg stretching, etc.) followed by running their specific races. The experimental procedure was conducted 6 days/week for 10 weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Athletes from 16 to 18 years old;
- Subjects underwent a physical examination before enrollment and showed no sign of illness or malaise.
Exclusion Criteria:
- Subjects were smokers or ergogenic aid users;
- Subjects had any metabolic, cardiovascular, renal, or liver diseases;
- Subjects had psychiatric disorders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Subjects ingested VAAM® for 10 weeks
Ten young athletes ingested Vespa amino acid mixture (VAAM®) for 10 weeks, divided into different meter race including 1500-, 800- and 400-meter races.
|
17 kinds of amino acids mixture in specific proportion
Other Names:
|
Experimental: Subjects ingested VAAM® for 6 weeks
Ten young athletes ingested Vespa amino acid mixture (VAAM®) for 6 weeks, divided into different meter race including 1500-, 800- and 400-meter races.
|
17 kinds of amino acids mixture in specific proportion
Other Names:
|
No Intervention: Subjects ingested nothing
Ten young athletes before ingesting Vespa amino acid mixture (VAAM®) , divided into different meter race including 1500-, 800- and 400-meter races.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
change of running time scores at 10 weeks
Time Frame: 10 weeks
|
10 weeks
|
change of the plasma lactic acid clearance rate after running at 10 weeks
Time Frame: 10 weeks
|
10 weeks
|
change of red blood cells after running at 10 weeks
Time Frame: 10 weeks
|
10 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sports Injury
-
Riphah International UniversityCompletedSports Physical Therapy | Sports InjuryPakistan
-
University of Alabama at BirminghamCompleted
-
University Rovira i VirgiliCompletedSports Physical Therapy | Injury;Sports | Musculoskeletal Injury | Biomechanical LesionsSpain
-
Linkoeping UniversitySwedish Athletics AssociationCompleted
-
Federation Internationale de Football AssociationActive, not recruiting
-
Peking University Third HospitalRecruiting
-
Sahlgrenska University Hospital, SwedenCompleted
-
Peking University Third HospitalRecruiting
Clinical Trials on Vespa amino acid mixture
-
Lund UniversityCompleted
-
Entrinsic Bioscience Inc.TerminatedInflammatory Bowel Diseases | Ileostomy - Stoma | Short Bowel SyndromeUnited States
-
Diego MorettiSwiss Federal Institute of Technology; Wageningen University and Research; St... and other collaboratorsCompletedMalnutrition; ProteinSwitzerland
-
Texas A&M UniversityUnknownChronic Obstructive Pulmonary DiseaseUnited States
-
Università degli Studi di BresciaCompletedDialysis | Uremia | Survival | Elderly (Aged >70) | Low Protein DietItaly
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHealthy | Obesity | Type 2 DiabetesUnited States
-
University GhentCompleted
-
Indonesia UniversityCompletedAdult Patients Undergoing ERCPIndonesia
-
Société des Produits Nestlé (SPN)Completed